I'm hoping Monday's presentations will give a bounce to over $5.00 again and then it will settle in above that range to at least $6.00.
From BarChart:
Ariad Pharmaceuticals (ARIA)
4.07-0.50 (-10.94%) 8:13P EST (NASDAQ)
Detailed Opinion as of Fri, Dec 6th, 2013 View Help
Show Signal Strength and Direction
Composite Indicators Signal
Get Chart Get Performance
TrendSpotter Buy
Short Term Indicators
Get Chart Get Performance
7 Day Average Directional Indicator Buy
More HOLDs after the next week: let's see if this is correct and
there is a significant correction to the drop last week.
MarketWatch's analyst consensus at $7.44 is much higher than what we're seeing on some scoreboards elsewhere,
taking into account that even with setbacks quarterly and annual revenues are expected to increase.
The company's announced budget-savings plans apparently meet with analysts' satisfaction however, of course it would be nice to regain the full potential and be able to continue development of all the promising molecules in the pipeline.
Would of course be ideal if some rumors about partnering bear out.
Just trying to balance all the doom and gloom while being realistic within the context of numbers!
Waiting for reviews of the presentations.
Snapshot
Average Recommendation: Hold
Average Target Price: 7.44
Number of Ratings: 22
Current Quarters Estimate: -0.46
FY Report Date: 12 / 2013
Current Year's Estimate: -1.56
Last Quarter's Earnings: -0.36
Median PE on CY Estimate: 9,999
Year Ago Earnings: -1.33
Next Fiscal Year Estimate: -1.00
Median PE on Next FY Estimate: 9,999
AI
